The PATHway Study: Primary Care Based Depression Prevention in Adolescents

NCT ID: NCT05203198

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-01

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality. To address this need, the investigators developed and evaluated the primary care based-technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT). The investigators will engage N=4 health systems representative of the United States health care system, and conduct a factorial design study to optimize the intervention in preparation for an implementation study and eventual dissemination.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

With more than 13% of adolescents diagnosed with depressive disorders each year, prevention of depressive disorders has become a key priority for the National Institute of Mental Health (NIMH). Unfortunately, the investigators have no widely available interventions to reduce morbidity and mortality (e.g. public health impact). To address this need, the investigators developed a multi-health system "collaboratory" to develop and evaluate the primary care based technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT) (14 adolescent, 5 parent modules). Using this health-system collaboratory model, the full CATCH-IT program (all modules), demonstrated evidence of efficacy in prevention of depressive episodes in phase-three clinical trials in the United States and China. However, like many "package" interventions, CATCH-IT became larger and more complex across efficacy trials. Thus, adolescents were less willing to complete all 14 modules, suggesting adolescent dose "tolerability" issues (e.g., satisfaction, acceptability and resource use, "time as cost"). Similarly, primary care practices have "scalability" challenges (acceptability, feasibility, resource use, cost), resulting in declining REACH (percent of at-risk youth who complete intervention). To prepare for implementation studies and dissemination, the investigators need to address adolescent tolerability and practice/health system scalability, while preserving efficacy. Multiphase Optimization Strategy (MOST) uses a systematic analytic approach and a factorial randomized clinical trial design to address efficacy, tolerability, and scalability, simultaneously. The investigators will use a MOST approach to optimize CATCH-IT for the prevention of depression (indicated prevention, i.e., elevated symptoms of depression) in practices and health systems representative of US geography and population. The theoretically grounded components of CATCH-IT selected for study and optimization include: behavioral activation, cognitive-behavioral therapy, interpersonal psychotherapy, and parent program. The investigators will use a 4-factor (2x2x2x2) fully crossed factorial design with N=16 cells (25 per cell, 15% dropout) to evaluate the contribution of each component. The investigators propose to randomize N=400 adolescents from multiple sites: Advocate-Aurora Health Care (n=200); Lurie Children's Hospital (n=70); NorthShore University HealthSystem (n=70); University of Chicago Comer Hospital (n=25); University of Texas (n=20); University of Illinois College of Medicine Peoria (n=15). The at-risk youth will be high school students 13 through 18 years old, not currently experiencing a mood disorder, but with subsyndromal symptoms of depression (moderate to high risk). Using the efficient factorial design, the investigators can assess the contribution to prevention efficacy of each component. Thus, the MOST study design will enable us to eliminate non-contributing components while preserving efficacy and to optimize CATCH-IT by strengthening tolerability and scalability by reducing "resource use." By reducing resource use, the investigators anticipate satisfaction and acceptability will also increase, preparing the way for an implementation trial and eventual US Preventive Services Task Force endorsement to support dissemination. Thus, the primary question is whether one component, or perhaps two, can demonstrate an equivalent effect to combinations of other components in terms of efficacy, whilst also demonstrating superior adolescent/family tolerability scalability over a 12-month follow-up.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Mental Disorder in Adolescence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

The Multiphase Optimization Strategy (MOST) will be utilized to optimize a primary care, technology-based intervention (CATCH-IT) for the prevention of depression in at-risk adolescents to optimize efficacy, tolerability and scalability for implementation studies and eventual dissemination. This MOST process includes: (1) theoretical organization of components, target behaviors and links to preventive outcomes (vulnerability and protective factors, likelihood of developing depressive episode), (2) selection of components for factorial design, (3) optimization criteria and (4) factorial design (randomization, intervention delivery, assessments, analysis and optimization). The theoretically grounded components selected are: (1) behavioral activation modules; (2) cognitive-behavioral therapy modules; (3) interpersonal psychotherapy modules; and (4) parent program modules.
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors
Subjects will know the condition to which they are randomized when opening their CATCH-IT login, as the number of components will be apparent on the sidebar of the webpage.

All clinical evaluators conducting the MINI Kid and other psychological assessments will work out of the Boston Call Center and they will be the only staff blinded to group assignment.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1. No adolescent modules + no parent modules

No adolescent nor parent modules will be offered to the participant.

Group Type NO_INTERVENTION

No interventions assigned to this group

2. Adolescent behavioral activation modules only

Adolescent behavioral activation modules only

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

3. Adolescent cognitive-behavioral therapy modules only

Adolescent cognitive-behavioral therapy modules only

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

4. Adolescent interpersonal therapy modules only

Adolescent interpersonal therapy modules only

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

5. Adolescent behavioral activation modules + cognitive-behavioral therapy modules

Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

6. Adolescent behavioral activation modules + interpersonal therapy modules

Adolescent behavioral activation modules Adolescent interpersonal therapy modules

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

7. Adolescent cognitive-behavioral therapy modules + interpersonal therapy modules

Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

8. Full Adolescent program only

Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

9. Parent program modules only

Parent program modules

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

10. Adolescent behavioral activation modules + parent program modules

Adolescent behavioral activation modules Parent program modules

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

11. Adolescent cognitive-behavioral therapy modules + parent program modules

Adolescent cognitive-behavioral therapy modules Parent program modules

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

12. Adolescent interpersonal therapy modules + parent program modules

Adolescent interpersonal therapy modules Parent Program

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

13. Adolescent behavioral activation + cognitive-behavioral therapy + parent program modules

Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Parent program modules

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

14. Adolescent behavioral activation + interpersonal therapy + parent program modules

Adolescent behavioral activation modules Adolescent interpersonal therapy modules Parent program modules

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

15. Adolescent cognitive-behavioral therapy + interpersonal therapy + parent program modules

Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules Parent program modules

Group Type EXPERIMENTAL

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

16. All adolescent + parent program modules

Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules Parent program modules

Group Type ACTIVE_COMPARATOR

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Intervention Type BEHAVIORAL

Self-directed, technology-based, depression prevention program for adolescents and parents.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Self-directed, technology-based, depression prevention program for adolescents and parents.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

CATCH-IT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adolescents ages 13 through 18 years, and
* Adolescents must be experiencing an elevated level of depressive symptoms (PHQ-9 = 5-18), and
* Adolescents will be included if they have had past depressive episode/s, but not if they are in a current depressive episode.

Exclusion Criteria

1. Outside age range:

1. 12 or younger
2. 19 or older
2. Adolescent is a non-English speaker/reader
3. On the PHQ-9 screening, depression symptom level is:

1. PHQ-9 = 4 or lower
2. PHQ-9 =19 or higher
4. As assessed by the MINI Kid, a current depressive episode
5. As assessed by the MINI Kid, adolescent meets DSM-5 criteria for a psychotic or bipolar disorder.
6. Currently using medication therapy for depression, anxiety, or other internalizing disorders.
7. Currently engaged in individual treatment for a mood disorder (assessed by BCC during phone screen)
8. Currently engaged in a cognitive-behavioral group or therapy (assessed by BCC during phone screen)
9. Any past psychiatric hospitalizations
10. Any past suicide attempt or incident of self-harm with moderate or greater lethality
11. Extreme, current drug/alcohol abuse (determined by clinician follow up following a score of 3 or greater on the CRAFFT)
12. Current suicidal thoughts

1. Eligibility will be determined on a case-by-case basis during the baseline PhQ-9 and MINI Kid assessment process and after a consultation with a licensed mental health clinician has taken place. If adolescent report suicidal ideation on the baseline PhQ-9, and found ineligible, the MINI Kid assessment may not be required.
2. Adolescents with current (within the past 6 months), active suicidal feelings will be excluded.
3. Adolescents with passive thoughts of death or suicide but report to the mental health clinician that they would never act on these thoughts may be admitted, depending on the severity of the risk.
4. Adolescents with past (greater than 6 months ago) ideation who are determined to be low risk will be admitted into the study if there has never been an attempt of moderate or greater lethality.
13. Significant reading impairment (a minimum sixth-grade reading level based on parental report) and/or significant intellectual or developmental disabilities
14. Not willing to comply with the study protocol
15. Did not complete phone assessment with MINI Kid by BCC
16. Not affiliated with any of the sites listed in Appendix A.
17. Parent/guardian does not speak English or Spanish
18. Parent/guardian has a cognitive or intellectual impairment
19. Participant Declined/Changed Mind/Uninterested in participating
Minimum Eligible Age

13 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wake Forest University Health Sciences

OTHER

Sponsor Role collaborator

Endeavor Health

OTHER

Sponsor Role collaborator

University of Chicago

OTHER

Sponsor Role collaborator

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

Mile Square Health Center

OTHER

Sponsor Role collaborator

Lawndale Christian Health Center

OTHER

Sponsor Role collaborator

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

Sponsor Role collaborator

University of Illinois at Chicago

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Benjamin Van Voorhees, MD, MPH

Professor and Head, Department of Pediatrics

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Benjamin W Van Voorhees, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

UIC, College of Medicine

Tracy RG Gladstone, PhD

Role: PRINCIPAL_INVESTIGATOR

Wellesley College

Calvin Rusiewski, MBBS

Role: STUDY_DIRECTOR

UIC, College of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States

Site Status

UI Health

Chicago, Illinois, United States

Site Status

University of Chicago Comer Children's Hospital

Chicago, Illinois, United States

Site Status

Northshore University HealthSystem

Glenview, Illinois, United States

Site Status

Advocate Aurora Health

Park Ridge, Illinois, United States

Site Status

UT Southwestern Medical Center

Dallas, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01MH124723-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

3R01MH124723-04S1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

CHAIRb 20080601

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.